PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson\'s disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Epistemonikos ID: b0afeca88852fbf4c0fb9032e985fdb6081a7093
First added on: May 07, 2024